Yüklüyor......
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma
Despite improvement in therapeutic efficacy, multiple myeloma (MM) remains incurable with a median survival of approximately 10 years. Gene-expression profiling (GEP) can be used to elucidate the molecular basis for resistance to chemotherapy through global assessment of molecular alterations that e...
Kaydedildi:
| Yayımlandı: | Int J Hematol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4433024/ https://ncbi.nlm.nih.gov/pubmed/22002477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-011-0948-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|